NSE · BSE · Real-time
High-value corporate events — new orders, fund raises, capacity expansions, and earning calls — analysed by AI the moment they hit the exchange.
Sudarshan Pharma Industries has approved the allotment of 8% senior unsecured Foreign Currency Convertible Bonds (FCCBs) worth USD 10 million, approximately ₹96 crore. This capital raise includes an option to procure an additional USD 10 million within 60 days to further bolster the company's financial position and growth initiatives.
Real-time NSE & BSE event alerts, AI-summarized filings, and instant order-win signals — free for 15 days, no card required.